Qiagen NV | QIA - Sales Revenues

Stock Price
42.05
Daily Change
0.66 1.58%
Monthly
-5.97%
Yearly
14.16%
Q1 Forecast
40.37

Qiagen NV reported $457.38M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
argenx SE USD 1.12B 132.91M Dec/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025